講演情報
[WS08-12-P]An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant
○Ryuta Uraki1,2,3, Maki Kiso3, Mutsumi Ito2, Seiya Yamayoshi1,2,3, Peter Halfmann4, Shilpi Jain5,6,7, Mehul S. Suthar5,6,7,8, Nao Jounai9, Kazuki Miyaji9, Fumihiko Takeshita9, Yoshihiro Kawaoka1,2,3,4 (1.National Center for Global Health and Medicine, 2.Division of Virology, Institute of Medical Science, The University of Tokyo, 3.The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (The UTOPIA Center), 4.Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 5.Department of Pediatrics, Emory University School of Medicine, 6.Emory Vaccine Center, 7.Emory National Primate Research Center, 8.Department of Microbiology and Immunology, Emory University, 9.Vaccine Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.)
キーワード:
SARS-CoV-2、mRNA vaccine、LNP-mRNA-RBD
閲覧にはパスワードが必要です
ログイン
または